COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review

por Ruiz, Juan I., Lopez-Olivo, Maria A., Geng, Yimin, Suarez-Almazor, Maria E.
Publicado 2023

Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study

por Lopez-Olivo, Maria A., Duhon, Gabrielle F., Ruiz, Juan I., Altan, Mehmet, Tawbi, Hussein, Diab, Adi, Bingham, Clifton O., Calabrese, Cassandra, Heredia, Natalia I., Volk, Robert J., Suarez-Almazor, Maria E.
Publicado 2023

Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism

por Clavijo, María Manuela, Vicente Reparaz, María de los Angeles, Ruiz, Juan I, Acuña, María Angeles, Casali, Claudia E, Aizpurua, María Florencia, Mahuad, Carolina V, Eciolaza, Sebastian, Ventura, Adriana, Garate, Gonzalo M
Publicado 2021

Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors

por Lopez-Olivo, Maria A., Kachira, Johncy J., Buni, Maryam, Kim, Sang Taek, Lu, Huifang, Tayar, Jean H., Duhon, Gabrielle F., Ruiz, Juan I., Bingham, Clifton O., Calabrese, Cassandra, Volk, Robert J., Suarez-Almazor, Maria E.
Publicado 2023